Medicare Enrolled

Dr. Robert Pyle, M.D.

Endocrinology · Palestine, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2217 S SYCAMORE ST, Palestine, TX 75801
9037293993
In practice since 2006 (19 years)
NPI: 1821007253 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pyle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pyle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pyle

Dr. Robert Pyle is an endocrinology in Palestine, TX, with 19 years in practice. Based on federal Medicare data, Dr. Pyle performed 24,415 Medicare services across 12,293 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pyle received a total of $2,700 from 12 pharmaceutical and/or device companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pyle is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in TX$ $2,700 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,415
Medicare services
Top 1% in TX for endocrinology
12,293
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,285 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)2,100$18$26
Blood draw (venipuncture)1,094$8$16
Comprehensive metabolic blood panel1,057$10$27
Complete blood count (CBC) with differential1,056$8$20
Urinalysis with microscopic exam1,022$3$9
Magnesium level test1,018$6$18
Creatine kinase (cardiac enzyme) level, total1,002$6$17
Free thyroxine (T4) test981$9$23
Thyroid hormone, t3 measurement, free979$16$44
Parathyroid hormone level test968$39$106
Lipid panel (cholesterol and triglycerides)967$13$35
Thyroid stimulating hormone (TSH) test949$16$43
Glycated protein level931$16$39
Vitamin B-12 level test922$14$39
C-peptide (protein) level875$20$54
Vitamin D level test840$28$70
Hemoglobin A1c test (diabetes monitoring)839$9$25
Cystatin c (enzyme inhibitor) level817$18$35
Microsomal antibodies (autoantibody) measurement664$14$38
Thyroglobulin (thyroid protein) antibody measurement656$15$41
Office visit, established patient (30-39 min)587$81$171
Insulin measurement, total566$11$30
Creatinine test (kidney function)452$5$14
Urine microalbumin test (kidney screening)444$5$15
Natriuretic peptide (heart and blood vessel protein) level438$37$87
Office visit, established patient, complex (40-54 min)382$117$241
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report234$24$74
Uric acid level test231$4$12
Phosphate level test226$5$13
C-reactive protein test (inflammation marker)223$5$14
Sed rate test (inflammation marker)220$3$7
Testosterone (hormone) level, total99$25$66
Ultrasound of both sides of head and neck blood flow96$26$417
New patient office visit, complex (60-74 min)80$136$343
PSA test (prostate cancer screening)72$17$47
Measurement of total estradiol (hormone)44$27$72
Ultrasound scan of head and neck soft tissue38$70$206
Office visit, established patient (20-29 min)33$66$121
Iron level test23$6$17
Ferritin level test (iron stores)22$13$35
Transferrin (iron binding protein) level22$12$24
Red blood count, manual test22$4$11
Prolactin (milk producing hormone) level20$19$50
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional18$16$40
New patient office visit (45-59 min)17$102$276
Gonadotropin, follicle stimulating (reproductive hormone) level16$18$48
Gonadotropin, luteinizing (reproductive hormone) level16$18$48
Ultrasound of leg arteries or artery grafts14$81$525
Ultrasound study of arm and leg arteries12$26$190
Folic acid level test11$14$38
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,700
Total received (2018-2024)
Avg $386/year across 7 years
Bottom 46% in TX for endocrinology
12
Companies
48
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,700 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$177
2023
$399
2022
$297
2021
$651
2020
$286
2019
$535
2018
$354

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$808
Amgen Inc.
$446
Medtronic, Inc.
$326
Boehringer Ingelheim Pharmaceuticals, Inc.
$314
Novo Nordisk Inc
$186
DEXCOM, INC.
$153
Medtronic MiniMed, Inc.
$136
Merck Sharp & Dohme Corporation
$74
Shire North American Group Inc
$71
Lilly USA, LLC
$70
Dexcom, Inc.
$62
SANOFI-AVENTIS U.S. LLC
$54
Top 3 companies account for 58.5% of total payments
Associated products mentioned in payments ›
DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · FARXIGA · INPEN SMART INSULIN DELIVERY SYSTEM · InPen · JARDIANCE · MINIMED 770G · MINIMED 780G · Minimed 630G · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · Ozempic · Prolia · RYBELSUS · Repatha · SOLIQUA · STEGLATRO · SYNJARDY · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a endocrinology in Palestine?
Compare endocrinologys in the Palestine area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
2
Per 100K population
3.5
County median income
$58,846
Nearest hospital
PALESTINE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pyle is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pyle experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Pyle performed 2,100 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pyle receive payments from pharmaceutical companies?
Yes. Dr. Pyle received a total of $2,700 from 12 companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pyle's costs compare to other endocrinologys in Palestine?
Dr. Pyle's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pyle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →